About Novozymes
Novozymes is a company based in Bags Sword (Denmark) founded in 2000 was acquired by Kerry in December 2023. Novozymes has completed 13 acquisitions, including Biota, Crop Bioscience Solutions and Delta Biotechnology. Novozymes offers products and services including Enzymes, Microbes, and Fermented Proteins. Novozymes operates in a competitive market with competitors including Evelo Biosciences, Seed, Seres Therapeutics, MaaT Pharma and Rebiotix, among others.
- Headquarter Bags Sword, Denmark
- Stage Public
-
Sectors
ConsumerHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Novozymes Biopharma Dk A/S
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Novozymes
Novozymes offers a comprehensive portfolio of products and services, including Enzymes, Microbes, and Fermented Proteins.
Catalyze biochemical reactions for efficient industrial processes.
Used in fermentation for applications in food and agriculture.
Enhance product development in household and health sectors.
People of Novozymes
Unlock access to complete
Software Development Team
106 people
Sales and Marketing
75 people
Senior Team
68 people
Leadership Team
58 people
Head Team
43 people
Product Management Team
35 people
Human Resources and Administration
24 people
Finance and Accounting
22 people
Unlock access to complete
Funding Insights of Novozymes
Investors in Novozymes
Novozymes has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include DOE, Kerry and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Energy sources and policies are managed by the DOE.
|
Locked | Locked | Locked |
Investor details for Novozymes
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Novozymes
Novozymes has strategically engaged in corporate development activities, having acquired 13 companies. Notable acquisitions include Biota, Crop Bioscience Solutions and Delta Biotechnology.
Investment portfolio details for Novozymes
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of recombinant protein products
|
Locked | Locked | 2020 | Locked | |
|
Environmental genomics services are delivered to the petroleum industry.
|
Locked | Locked | 2013 | Locked | |
|
Probiotic and prebiotic nutraceuticals are manufactured for health disorders.
|
Locked | Locked | 2013 | Locked |
Complete acquisition details for Novozymes
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Novozymes
Detailed financials for Novozymes
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Novozymes Comparisons
Peer comparison for Novozymes
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Novozymes
Novozymes operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evelo Biosciences, Seed, Seres Therapeutics, MaaT Pharma and Rebiotix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for inflammatory diseases, COVID-19, and cancer are developed.
|
|
| Locked | Locked | Locked |
Synbiotics are developed for simulating the gut microbiome.
|
|
| Locked | Locked | Locked |
Microbiome therapeutics are developed to address diverse diseases.
|
|
| Locked | Locked | Locked |
Microbiome therapies are developed for treating intestinal dysbiosis diseases.
|
|
| Locked | Locked | Locked |
Microbiota restoration therapies are developed for gastrointestinal infections.
|
Detailed competitors of Novozymes
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Novozymes
Complete news archive for Novozymes
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Novozymes
Novozymes was founded in 2000.
Novozymes is headquartered in Bags Sword, Denmark.
Ester Baiget is the current CEO of Novozymes.
Founded in 2000 and headquartered in Bagsvaerd, Denmark, biosolutions and enzymes are developed for multiple industries through biotechnology. Operations focus on enzymes, microorganisms, and precision proteins to support sustainable products. Natural oral health treatments are provided using probiotics, enzymes, and bioactives to influence oral microbiota for human health. Ronozyme feed enzymes are offered to enhance animal husbandry practices.
Novozymes's top competitors include Seres Therapeutics, Seed and MaaT Pharma.
Novozymes offers Enzymes, Microbes, and Fermented Proteins.
Novozymes has made 13 acquisitions, including Biota, Crop Bioscience Solutions, and Delta Biotechnology.
Novozymes has 5 investors. Key investors include DOE, Kerry, European Union, IFU, and OSTI.GOV.